Takeda Targets Rival Over Generic Diabetes Drug
Takeda Pharmaceutical Co. Ltd. launched its latest attack Wednesday in New York federal court seeking to prevent generic-drug maker Hetero Drugs Ltd. and several subsidiaries from producing their own version of...To view the full article, register now.
Already a subscriber? Click here to view full article